280 related articles for article (PubMed ID: 35761367)
1. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
[TBL] [Abstract][Full Text] [Related]
2. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
[TBL] [Abstract][Full Text] [Related]
3. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.
Shroff R; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu S; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Ranchin B; Samaille C; Shenoy M; Sinha M; Smith C; Spasojevic B; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schaefer F; Schmitt CP
BMC Nephrol; 2018 Aug; 19(1):199. PubMed ID: 30097064
[TBL] [Abstract][Full Text] [Related]
4. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.
Peters SA; Bots ML; Canaud B; Davenport A; Grooteman MP; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ;
Nephrol Dial Transplant; 2016 Jun; 31(6):978-84. PubMed ID: 26492924
[TBL] [Abstract][Full Text] [Related]
5. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
[TBL] [Abstract][Full Text] [Related]
6. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study.
Ok E; Asci G; Toz H; Ok ES; Kircelli F; Yilmaz M; Hur E; Demirci MS; Demirci C; Duman S; Basci A; Adam SM; Isik IO; Zengin M; Suleymanlar G; Yilmaz ME; Ozkahya M;
Nephrol Dial Transplant; 2013 Jan; 28(1):192-202. PubMed ID: 23229932
[TBL] [Abstract][Full Text] [Related]
7. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.
Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R
Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931
[TBL] [Abstract][Full Text] [Related]
8. Design and methodology of the impact of HemoDiaFIlTration on physical activity and self-reported outcomes: a randomized controlled trial (HDFIT trial) in Brazil.
Pecoits-Filho R; Larkin JW; Poli-de-Figueiredo CE; Cuvello Neto AL; Barra AB; Canhada S; de Campos LG; Woehl J; Gonçalves PB; Han H; de Moraes TP; Raimann JG; Canziani MEF;
BMC Nephrol; 2019 Mar; 20(1):98. PubMed ID: 30894141
[TBL] [Abstract][Full Text] [Related]
9. The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials.
Vernooij RWM; Law W; Peters SAE; Canaud B; Davenport A; Grooteman MPC; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ; Bots ML;
BMC Nephrol; 2021 Feb; 22(1):70. PubMed ID: 33632160
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients.
Bellien J; Fréguin-Bouilland C; Joannidès R; Hanoy M; Rémy-Jouet I; Monteil C; Iacob M; Martin L; Renet S; Vendeville C; Godin M; Thuillez C; Le Roy F
Nephrol Dial Transplant; 2014 Feb; 29(2):414-22. PubMed ID: 24235073
[TBL] [Abstract][Full Text] [Related]
11. CONVINCE in the context of existing evidence on haemodiafiltration.
Vernooij RWM; Bots ML; Strippoli GFM; Canaud B; Cromm K; Woodward M; Blankestijn PJ;
Nephrol Dial Transplant; 2022 May; 37(6):1006-1013. PubMed ID: 35098994
[TBL] [Abstract][Full Text] [Related]
12. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study.
Wizemann V; Lotz C; Techert F; Uthoff S
Nephrol Dial Transplant; 2000; 15 Suppl 1():43-8. PubMed ID: 10737166
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation.
Klingel R; Schaefer M; Schwarting A; Himmelsbach F; Altes U; Uhlenbusch-Körwer I; Hafner G
Nephrol Dial Transplant; 2004 Jan; 19(1):164-70. PubMed ID: 14671052
[TBL] [Abstract][Full Text] [Related]
14. Is hemodiafiltration superior to high-flow hemodialysis in reducing all-cause and cardiovascular mortality in kidney failure patients? A meta-analysis of randomized controlled trials.
Bignardi PR; Delfino VDA
Hemodial Int; 2024 Apr; 28(2):139-147. PubMed ID: 38369730
[TBL] [Abstract][Full Text] [Related]
15. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study.
Molina P; Vizcaíno B; Molina MD; Beltrán S; González-Moya M; Mora A; Castro-Alonso C; Kanter J; Ávila AI; Górriz JL; Estañ N; Pallardó LM; Fouque D; Carrero JJ
Nephrol Dial Transplant; 2018 Jul; 33(7):1223-1235. PubMed ID: 29370428
[TBL] [Abstract][Full Text] [Related]
16. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
Rabindranath KS; Strippoli GF; Daly C; Roderick PJ; Wallace S; MacLeod AM
Cochrane Database Syst Rev; 2006 Oct; (4):CD006258. PubMed ID: 17054289
[TBL] [Abstract][Full Text] [Related]
17. Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol.
Lu W; Jiang GR;
BMJ Open; 2018 Jul; 8(7):e022169. PubMed ID: 30056391
[TBL] [Abstract][Full Text] [Related]
18. Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.
Snauwaert E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Saoussen K; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Shroff R; Eloot S
Nephrol Dial Transplant; 2020 Apr; 35(4):648-656. PubMed ID: 31361315
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
20. The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study.
Mazairac AH; Blankestijn PJ; Grooteman MP; Penne EL; van der Weerd NC; den Hoedt CH; Buskens E; van den Dorpel MA; ter Wee PM; Nubé MJ; Bots ML; de Wit GA;
Nephrol Dial Transplant; 2013 Jul; 28(7):1865-73. PubMed ID: 23766337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
